All Articles in: Techniques

Port Site Closure Herniations Under the Microscope in New Comparative StudyJanuary 20, 2016

neoSurgical® begins postmarket surveillance study of neoClose® versus standard of care for closing port site incisions in Lap and Robotic surgeries

Posted in: , ,


CE Mark for Advanced Cooling Therapy’s Novel Esophageal Cooling DeviceApril 9, 2014

An emerging medical device manufacturing company (that we’d never come across until now), Advanced Cooling Therapy (ACT), has received CE marking for its first product, the Esophageal Cooling Device (ECD) to control patient temperature. The product is now available to medical professionals in Europe.

Posted in: ,


European Clot Management Device Market To Exceed $170 Million By 2022September 5, 2013

According to global market intelligence company Millennium Research Group, the European market for clot management devices will see moderate growth through 2022. Although a number of segments are mature, fast-growing segments such as endovascular treatments for acute ischemic stroke and venous thromboembolism underpin the growth forecast.

Posted in: , , , , ,


Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Hemasorb Plus™ Resorbable Hemostatic Bone Putty

Hemasorb Plus is provided ready-to-use and achieves hemostasis by mechanical tamponade. Its proprietary formulation is comprised of granular hydroxyapatite/beta-tricalcium phosphate and water soluble components that are fully synthetic and absorbable.

Posted in: , ,


CE Mark for Cormedix Neutrolin® Catheter Lock SolutionJuly 8, 2013

CorMedix Inc. has gained CE Mark approval for Neutrolin®, a catheter lock solution for patients with central venous catheters on hemodialysis secondary to advanced chronic kidney disease.

Posted in: , ,


Teleflex Hopes Eon Surgical Acquisition Will Help It Accelerate Microlaparoscopy AdoptionJune 10, 2013

Device company Teleflex Inc. is to acquire Israeli company Eon Surgical, Ltd. in a deal, the terms of which have not been disclosed. Eon Surgical is described as a late stage development company that has advanced a minimally invasive microlaparoscopy …

Posted in: , , ,


Valtech Cardio Treats First Mitral Regurgitation Patients with Percutaneous Annuloplasty Device Without Open-Heart SurgeryMay 17, 2013

Valtech Cardio Ltd., a medical device company that develops solutions for mitral valve repair and replacement, announced today that two patients diagnosed with severe mitral regurgitation have been treated successfully with the Transfemoral Cardioband™ Annuloplasty System

Posted in: ,


UK Sees Significant Increase In Organ Donation Due To NICE GuidanceApril 11, 2013

Difficult decision that it is, the chance to give someone else life after you or your loved one has died can be a source of great and enduring comfort. Two new initiatives driven by UK’s NICE have helped see the number of donations rise dramatically, yet three people a day still die waiting.

Posted in: , ,


CE Mark And EU Launch For Apollo Endosurgery’s OverStitch™ Endoscopic Suturing PlatformApril 3, 2013

Endoscopic device company Apollo Endosurgery, Inc., has announced that its OverStitch™ Endoscopic Suturing System has gained European CE Mark approval. The company plans to immediately launch the system to select centers in several European countries.

Posted in: , , , ,


ROX Medical’s Resistant Hypertension Trial Under Way In LondonMarch 26, 2013

London’s Barts Hospital has enrolled its first patients in the ROX Medical CONTROL-HTN international randomized controlled hypertension trial. The study is evaluating the ROX FLOW procedure, which creates a small connection between artery and vein in the upper leg for the treatment of resistant hypertension.

Posted in: , , ,


Treating Hip Fracture….Before It Happens!March 25, 2013

If you’re of a certain vintage, if your bones are osteoporotic and you suffer a hip fracture, you are at risk of suffering one on the other side. In a piece of potentially smart-thinking a Bordeaux company has a minimally invasive device that might protect you against that eventuality.

Posted in: , , ,


Israel’s Premia Spine Launches Alternative To Spinal Fusion In SpondylolisthesisMarch 7, 2013

Israeli company Premia Spine has developed an implant which it says offers patients with certain spinal disorders an alternative to traditional fusion surgeries. The company says it enables a quicker recovery and greatly reduces the risk of reoperation.

Posted in: , ,


CE Mark For NeoChord’s DS1000 Mitral Valve Repair DeviceJanuary 7, 2013

Mitral valve repair specialist company NeoChord, has received CE-marking for its technology that allows the implantation of artificial chordae tendinae, a proven technique for the repair of mitral valve prolapse, via a transapical, off-pump procedure.

Posted in: , ,


FDA Clears Soft Tissue Regeneration’s Rotator Cuff Repair Device

Early stage orthopedic device company, Soft Tissue Regeneration, has developed a breakthrough tissue engineering platform used to regenerate ligaments and tendons. The company has announced that it has received FDA clearance to market its STR GRAFT, a biodegradable scaffold used for soft tissue augmentation and rotator cuff repair.

Posted in: , ,


Five Year Results From ClosureFast™ Study Show Durable Treatment Success In CVI Patients

Covidien is trumpeting the five-year results of its ClosureFast™ Long-Term European Multi-Centre Study in patients with Chronic Venous Insufficiency. 92% of patients still had effective occlusion of target vessels after five years, supporting the claim that the treatment is durable in the longer term.

Posted in: , , ,


Green Light For Study Means Ultimate Test For Ventricular Unloading TheoryDecember 20, 2012

A new study, entitled “TandemHeart to Reduce Infarct Size” (TRIS) will determine effect of ventricular unloading on myocardial salvage after acute myocardial infarction.

Posted in: , ,


<< Previous Articles